120 related articles for article (PubMed ID: 22361419)
1. Moxifloxacin for tuberculosis.
Mendel C; Springsklee M
Lancet Infect Dis; 2012 Mar; 12(3):176-7; author reply 177-8. PubMed ID: 22361419
[No Abstract] [Full Text] [Related]
2. Moxifloxacin for tuberculosis.
Singh KP; Brown M; Murphy ME; Gillespie SH
Lancet Infect Dis; 2012 Mar; 12(3):176; author reply 177-8. PubMed ID: 22361420
[No Abstract] [Full Text] [Related]
3. Rational use of moxifloxacin for tuberculosis treatment.
Cox H; Ford N; Keshavjee S; McDermid C; von Schoen-Angerer T; Mitnick C; Goemaere E
Lancet Infect Dis; 2011 Apr; 11(4):259-60. PubMed ID: 21453864
[No Abstract] [Full Text] [Related]
4. Should moxifloxacin be substituted for isoniazid as a first-line antituberculosis drug?
Mohapatra PR
Am J Respir Crit Care Med; 2009 Oct; 180(7):686; author reply 686-7. PubMed ID: 19762595
[No Abstract] [Full Text] [Related]
5. Moxifloxacin.
Tuberculosis (Edinb); 2008 Mar; 88(2):127-31. PubMed ID: 18486050
[No Abstract] [Full Text] [Related]
6. PanACEA: a new approach to tuberculosis research.
Burki T
Lancet Infect Dis; 2012 Mar; 12(3):184-5. PubMed ID: 22468276
[No Abstract] [Full Text] [Related]
7. New drug combination for TB is tested in unique trial.
Kmietowicz Z
BMJ; 2012 Jul; 345():e5060. PubMed ID: 22833631
[No Abstract] [Full Text] [Related]
8. Moxifloxacin treatment of tuberculosis.
Gosling R; Gillespie S
Antimicrob Agents Chemother; 2004 Sep; 48(9):3642; author reply 3642-3. PubMed ID: 15328148
[No Abstract] [Full Text] [Related]
9. [Study of antituberculous activity of moxifloxacin conjugate with macrophage scavenger-receptor ligand].
Azaev MSh; Agafonov AP; Bodnev SA; Blinov VM
Antibiot Khimioter; 2006; 51(11-12):7-10. PubMed ID: 18318141
[TBL] [Abstract][Full Text] [Related]
10. Promising results for new tuberculosis therapy.
Bagchi S
CMAJ; 2008 Jan; 178(1):19. PubMed ID: 18166722
[No Abstract] [Full Text] [Related]
11. Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.
Pletz MW; De Roux A; Roth A; Neumann KH; Mauch H; Lode H
Antimicrob Agents Chemother; 2004 Mar; 48(3):780-2. PubMed ID: 14982764
[TBL] [Abstract][Full Text] [Related]
12. Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.
Gumbo T; Louie A; Deziel MR; Parsons LM; Salfinger M; Drusano GL
J Infect Dis; 2004 Nov; 190(9):1642-51. PubMed ID: 15478070
[TBL] [Abstract][Full Text] [Related]
13. Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens.
Roberts CH; Smith C; Breen R; Gadhok R; Murphy M; Aryee A; Cropley I; Bhagani S; Hopkins S; Lipman M
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1275-6. PubMed ID: 21943863
[No Abstract] [Full Text] [Related]
14. Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model.
Balasubramanian V; Solapure S; Gaonkar S; Mahesh Kumar KN; Shandil RK; Deshpande A; Kumar N; Vishwas KG; Panduga V; Reddy J; Ganguly S; Louie A; Drusano GL
Antimicrob Agents Chemother; 2012 Jun; 56(6):3054-7. PubMed ID: 22470118
[TBL] [Abstract][Full Text] [Related]
15. Novel drug combination for tuberculosis to be tested across 50 sites.
Bagcchi S
BMJ; 2014 May; 348():g3535. PubMed ID: 24868091
[No Abstract] [Full Text] [Related]
16. Drug combo speeds up TB treatment.
AIDS Patient Care STDS; 2007 Oct; 21(10):783-4. PubMed ID: 17949277
[No Abstract] [Full Text] [Related]
17. Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model.
Ginsburg AS; Sun R; Calamita H; Scott CP; Bishai WR; Grosset JH
Antimicrob Agents Chemother; 2005 Sep; 49(9):3977-9. PubMed ID: 16127087
[TBL] [Abstract][Full Text] [Related]
18. Minimising moxifloxacin resistance with tuberculosis.
Drlica K; Zhao X; Kreiswirth B
Lancet Infect Dis; 2008 May; 8(5):273-5. PubMed ID: 18471768
[No Abstract] [Full Text] [Related]
19. Moxifloxacin versus ethambutol in initial tuberculosis treatment.
Chang KC; Leung CC
Lancet; 2009 Jun; 373(9682):2197-8; author reply 2198-9. PubMed ID: 19560596
[No Abstract] [Full Text] [Related]
20. [Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains].
Mozhokina GN; Sokolova GB; Dashieva DG; Mikhaĭlova LP; Elistratova NA
Probl Tuberk Bolezn Legk; 2005; (2):19-22. PubMed ID: 15881962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]